MesotheliomaCenter's

Mesothelioma-Line

Curated Journal Articles on Mesothelioma

Category Archives: Survival

Evaluating quality of life and cost implications of prophylactic radiotherapy in mesothelioma: Health economic analysis of the SMART trial

PLoS One 2018 February 5 [Link] Stewart SA, Clive AO, Maskell NA, Penz E Abstract BACKGROUND: The SMART trial is a UK-based, multicentre RCT comparing prophylactic radiotherapy and symptom-based (deferred) radiotherapy in 203 patients with Malignant Pleural Mesothelioma who had undergone large bore pleural interventions. Using costs and quality of life data collected alongside the […]

February 6, 2018

Pleural, Radiation, Radiotherapy, Survival
Comments Off on Evaluating quality of life and cost implications of prophylactic radiotherapy in mesothelioma: Health economic analysis of the SMART trial

Progress in the Management of Advanced Thoracic Malignancies in 2017

Journal of Thoracic Oncology 2018 January 10 [Epub ahead of print] [Link] Ferrara R, Mezquita L, Besse B Abstract The treatment paradigm of non-small cell lung cancer (NSCLC) underwent a major revolution during the course of 2017. Immune checkpoint inhibitors (ICIs) brought remarkable improvements in response and overall survival (OS) both in unselected pretreated patients […]

January 22, 2018

Full Archive, Lung Cancer, Survival
Comments Off on Progress in the Management of Advanced Thoracic Malignancies in 2017

Biomarker-Integrated Neoadjuvant Dasatinib Trial in Resectable Malignant Pleural Mesothelioma

Journal of Thoracic Oncology 2017 December [Epub ahead of print] [Link] Tsao AS et.al. Abstract Window-of-opportunity trials in malignant pleural mesothelioma (MPM) are challenging but can yield important translational information about a novel agent. We treated MPM patients (n=24) with 4 weeks of oral dasatinib followed by surgery with or without radiotherapy and then an […]

January 20, 2018

Biomarkers, Chemotherapy, Full Archive, Kinase Inhibitors, Survival
Comments Off on Biomarker-Integrated Neoadjuvant Dasatinib Trial in Resectable Malignant Pleural Mesothelioma

Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: a multi-institutional study

Modern Pathology 2018 January 12 [Epub ahead of print] [Link] Rosen LE et.al. Abstract A recently described nuclear grading system predicted survival in patients with epithelioid malignant pleural mesothelioma. The current study was undertaken to validate the grading system and to identify additional prognostic factors. We analyzed cases of epithelioid malignant pleural mesothelioma from 17 […]

January 17, 2018

Epithelioid, Full Archive, Pleural, Survival
Comments Off on Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: a multi-institutional study

National Trends in the Epidemiology of Malignant Pleural Mesothelioma: A National Cancer Data Base Study

The Annals of Thoracic Surgery 2017 December [Epub ahead of print] [Link] Saddoughi SA, Abdelsattar ZM, Blackmon SH Abstract BACKGROUND: Malignant pleural mesothelioma (MPM) remains an aggressive malignancy that is difficult to cure. However, the treatment paradigm of MPM has evolved, and the national practice patterns are unknown. This study examined the national trends in […]

December 14, 2017

Biphasic or Mixed, Chemotherapy, Epithelioid, Full Archive, Radiation, Sarcomatoid, Surgery, Survival, Trimodality or Mulitmodality Therapy
Comments Off on National Trends in the Epidemiology of Malignant Pleural Mesothelioma: A National Cancer Data Base Study

Phlebotomy as a preventive measure for crocidolite-induced mesothelioma in male rats

Cancer Science 2017 November 29 [Epub ahead of print] [Link] Ohara Y, Chew SH, Shibata T, Okazaki Y, Yamashita K, Toyokuni S Abstract Malignant mesothelioma (MM) is a rare but socially important neoplasm due to its association with asbestos exposure. While MM is difficult to diagnose at an early stage, there are no particularly effective […]

December 10, 2017

Case Study, Full Archive, Sarcomatoid, Surgery, Survival
Comments Off on Phlebotomy as a preventive measure for crocidolite-induced mesothelioma in male rats

Patterns of care and survival among patients with malignant mesothelioma in the United States

Lung Cancer 2017 October [Epub 2017 August 10] [Link] Enewold L, Sharon E, Thomas A Abstract BACKGROUND: Mesothelioma is a rare malignancy that is associated with poor survival. This study aimed to describe the patterns of care and subsequent survival among malignant mesothelioma patients in the United States, while adjusting for patient demographics and comorbidities. […]

December 7, 2017

Case Study, Full Archive, Survival
Comments Off on Patterns of care and survival among patients with malignant mesothelioma in the United States

Diaphragm and lung-preserving surgery with hyperthermic chemotherapy for malignant pleural mesothelioma: A 10-year experience

December 6, 2017

Biphasic or Mixed, Chemotherapy, Epithelioid, Full Archive, Pleural, Pleurectomy/decortication, Survival
Comments Off on Diaphragm and lung-preserving surgery with hyperthermic chemotherapy for malignant pleural mesothelioma: A 10-year experience

The Effect of Aquaporin 1-Inhibition on Vasculogenic Mimicry in Malignant Mesothelioma

International Journal of Molecular Services 2017 November [Link] Pulford E, McEvoy J, Hocking A, Prabhakaran S, Griggs K, Klebe S Abstract Malignant mesothelioma (MM) is an aggressive malignancy of the serosal membranes, with poor overall survival and quality of life. Limited targeted treatment strategies exist due to restricted knowledge of pathogenic pathways. Vasculogenic mimicry (VM) […]

November 11, 2017

Bevacizumab (Avastatin), Full Archive, Survival
Comments Off on The Effect of Aquaporin 1-Inhibition on Vasculogenic Mimicry in Malignant Mesothelioma

Epidemiology of malignant peritoneal mesothelioma: A population-based study

Cancer Epidemiology 2017 October [Epub ahead of print] [Link] Salo SAS, Ilonen I, Laaksonen S, Myllärniemi M, Salo JA, Rantanen T Abstract BACKGROUND: Malignant peritoneal mesothelioma (MPeM) is a rare cancer of the mesothelial cells in the peritoneum with poor prognosis. Earlier reports from other countries indicate an incidence of 0.2-3 new cases per million […]

November 4, 2017

Full Archive, Occupational Asbestos Exposure, Peritoneal (Abdominal Mesothelioma), Survival
Comments Off on Epidemiology of malignant peritoneal mesothelioma: A population-based study